United States · 
What does New Science Venture invest in?
New Science Venture invests most often at Series B and Series A (63% of the rounds on record), in sectors such as Ict, Telco and Telecommunication.
New Science Venture highlights
- 01
4 cheques in the last 12 months
- 02
Mostly Series B and Series A: 63% of its rounds
- 03
Sole investor in 5 rounds, median $6.5M
- 04
7 exits from the portfolio
What they do
New Science Ventures, LLC (NSV) is a Connecticut and London-based venture capital firm which invests in companies using novel scientific approaches in the Life Sciences and Information Technology sectors.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- IctTelcoTelecommunication
- Based in
- Greenwich, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first50 appearances
- 2026
4 rounds
- Oct
- Oct
- Oct
- Sept
- 2025
1 round
- Aug
- 2019
2 rounds
- Jul
- May
- 2018
1 round
- Sept
- 2017
1 round
- Jan
- 2016
4 rounds
- Nov
- Sept
- Sept
- Aug
- 2015
7 rounds
- Nov
- Nov
- Sept
- Sept
- Sept
- Apr
- Jan
- 2014
5 rounds
- Oct
- Sept
- Mar
- Jan
- Jan
- 2013
2 rounds
- Nov
- Oct
- 2012
6 rounds
- Nov
- Aug
- Jul
- Feb
- Feb
- Feb
- 2011
3 rounds
- Nov
- May
- Apr
- 2010
2 rounds
- Jun
- Mar
- 2009
2 rounds
- Mar
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration7 named
AAAndrew AbramsMemberiForm ADV
BMBrenda MarexChief Financial Officer, MemberiForm ADV
JBJean-Pierre BizetMemberiForm ADV
JHJonny HeController, MemberiForm ADV
RMRaju MohanMemberiForm ADV
SSSomasundaram SubramaniamMember, Managing DirectoriForm ADV
TJThomas J A LavinChief Operating Officer, MemberiForm ADV
We also hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$990Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- NSV Management LLC
- SEC number
- CRD 162486
What they claim to have backed
From their own portfolio page (on their website)
18 of 31 we have independently watched raise
CaringoDaliwirelessDustidentityFerricGlydwaysGtxcelKateevaNorthseatherapeuticsNovadipOscpParagrafPlanetiqPromaxoResolvetherapeuticsSagence-aiTigerconnectVuvanalyticsZeotapAntevianetworksAvariwirelessBiomodalIcadmedInvestor PortalLightningsiteLwallMorroweyewearMyrtlePakal-techTrellisbioVentyxbioVoragotech
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed7 in all
Seahorse BioscienceBought by Agilent Technologies$235MSept 2015
CellerationBought by Alliqua$30MFeb 2015
FlowCardiaBought by C. R. BardUndisclosedMay 2010
Ception TherapeuticsBought by Cephalon$250MFeb 2010
BioProcessorsBought by Seahorse BioscienceUndisclosedMar 2009
An exit counts when it came after the firm's first round in the company. From historical deal records.